Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

SHA:688193 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	136.97	97.44	261.58	609.57	298.93	197.94
Short-Term Investments	25.03	29.66	29.2	125.66	-	-
Trading Asset Securities	622.82	693.47	510.96	50.21	530.98	-
Cash & Short-Term Investments	784.82	820.56	801.74	785.44	829.91	197.94
Cash Growth	-2.07%	2.35%	2.08%	-5.36%	319.27%	15.10%
Accounts Receivable	47.4	45.05	49.37	77.6	105.13	55.5
Other Receivables	1.05	1.71	2.64	4.83	3.54	4.29
Receivables	48.45	46.75	52.01	82.43	108.66	59.79
Inventory	19	21.24	25.14	28.6	28.29	19.39
Other Current Assets	5.69	2.11	5.86	2.67	5.72	5.42
Total Current Assets	857.95	890.66	884.74	899.14	972.58	282.54
Property, Plant & Equipment	66.81	73.55	82.22	92.72	100.91	87.64
Long-Term Investments	-	-	-	40.77	-	-
Other Intangible Assets	0.19	0.26	0.41	0.45	0.66	0.6
Long-Term Deferred Tax Assets	19.37	20.11	20.24	12.96	9.63	3.23
Long-Term Deferred Charges	4.17	5.59	6.74	8.3	3.73	3.92
Other Long-Term Assets	-	-	-	0.38	1.21	0.68
Total Assets	948.49	990.17	994.36	1,055	1,089	378.61

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.25	2.7	3.04	4.09	11.38	9.84
Accrued Expenses	46.14	51.09	55.68	58.65	65.77	36.96
Current Portion of Leases	0.6	2.7	1.91	2.93	2.6	1.88
Current Income Taxes Payable	0.24	0.25	0.25	1	1.12	2.39
Current Unearned Revenue	3.77	6.59	9.01	5.58	7.33	9.22
Other Current Liabilities	5.45	5.66	4.52	6.21	7.26	6.02
Total Current Liabilities	57.44	68.97	74.42	78.45	95.46	66.31
Long-Term Leases	4.1	3.36	2.33	4.09	7.91	2.11
Long-Term Unearned Revenue	2.89	3.89	5.72	9.42	22.2	22.2
Long-Term Deferred Tax Liabilities	-	-	-	-	1.72	-
Other Long-Term Liabilities	-	0.03	0.01	0.01	0.05	0.24
Total Liabilities	64.42	76.26	82.48	91.97	127.34	90.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	40.07	40.07	40	40	40	30
Additional Paid-In Capital	780.2	779.81	777.44	773.7	776.23	135.44
Retained Earnings	101.06	130.27	129.87	149.39	146.13	122.8
Treasury Stock	-35.66	-35.66	-35.66	-	-	-
Comprehensive Income & Other	-1.61	-0.58	0.23	-0.35	-0.97	-0.49
Shareholders' Equity	884.07	913.91	911.88	962.74	961.38	287.75
Total Liabilities & Equity	948.49	990.17	994.36	1,055	1,089	378.61

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.69	6.06	4.24	7.02	10.51	3.99
Net Cash (Debt)	780.12	814.51	797.51	778.42	819.4	193.95
Net Cash Growth	-2.10%	2.13%	2.45%	-5.00%	322.47%	15.36%
Net Cash Per Share	19.73	20.99	20.42	19.79	21.42	6.39
Filing Date Shares Outstanding	38.78	38.78	38.71	40	40	30
Total Common Shares Outstanding	38.78	38.78	38.71	40	40	30
Working Capital	800.51	821.69	810.33	820.69	877.12	216.23
Book Value Per Share	22.80	23.57	23.56	24.07	24.03	9.59
Tangible Book Value	883.88	913.65	911.47	962.29	960.72	287.15
Tangible Book Value Per Share	22.79	23.56	23.55	24.06	24.02	9.57
Buildings	58.85	58.85	58.85	58.85	58.47	58.47
Machinery	74.58	74.76	74.51	71.85	67.39	48.02
Construction In Progress	-	-	0.41	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error